16 Feb Cellaion

Posted at 18:02h in by Jancee Curl

Etienne Sokal, M.D., Ph.D., CEO

April 21 | 2:15pm | Gaudi 2 Ballroom

Mont-Saint-Guibert, Belgium

(Private)

In-Person Presentation

Cellaïon is a new company created in 2021, using cell signaling technology to treat life threatening liver diseases. The company is currently in phase IIB clinical development, actively recruiting, in Acute on Chronic Liver Failure.

www.cellaion.com

About the Event

The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.

Dates & Location

April 20-22, 2022
Hotel Arts Barcelona
Marina 19-21
Barcelona, Spain

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions